George Dranitsaris

5PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 27, 2023
Diagnosis and management of systemic mastocytosis in a community hematology setting.

George Dranitsaris, Heather Neuhalfen, Aaron Peevyhouse

|May 02, 2022
A real-world study to evaluate the safety and efficacy of three injectable neurokinin-1 receptor antagonist formulations for the prevention of chemotherapy-induced nausea and vomiting in cancer patients.

George Dranitsaris, Mehdi Moezi, Kate Dobson

|Mar 30, 2019
Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis.

P Ryan, A McBride, D Ray

|Feb 17, 2017
Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and Austria.

George Dranitsaris, Lesley G Shane, Jean-Philippe Galanaud

Pageof 1